Metrion Biosciences Ltd, a leading contract research organisation based in Great Britain, specialises in ion channel drug discovery and safety pharmacology. Founded in 2013, the company has rapidly established itself as a key player in the biotechnology sector, providing innovative solutions to pharmaceutical and biotech clients. With headquarters in Cambridge and operational reach across Europe and North America, Metrion offers a unique suite of services, including bespoke ion channel screening and advanced electrophysiology. Their commitment to scientific excellence and customer-focused approach has garnered recognition within the industry, positioning them as a trusted partner for drug development. Metrion's state-of-the-art technology and expertise in ion channel pharmacology set them apart, making significant contributions to the advancement of therapeutic research.
How does Metrion Biosciences Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Metrion Biosciences Ltd's score of 23 is lower than 64% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Metrion Biosciences Ltd, headquartered in Great Britain, currently does not have available carbon emissions data for recent years. As such, specific figures regarding their emissions in kg CO2e, including Scope 1, 2, or 3 emissions, are not provided. In the absence of concrete emissions data, it is important to note that Metrion Biosciences Ltd has not publicly outlined any specific reduction targets or climate commitments. This lack of documented initiatives may reflect a broader industry context where many companies are increasingly focusing on sustainability and carbon neutrality. As the company continues to operate, it may consider establishing measurable climate commitments and reduction strategies to align with global sustainability trends and expectations.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Metrion Biosciences Ltd is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.